Case description

In 1970, a 27-year-old woman presented with viral myocarditis and third-degree atrioventricular block, with an electrocardiogram showing a heart rate of 23 b.p.m. Her severely bradycardic condition led to frequent syncopal episodes. Given the limited therapeutic options at the time, she was bedridden for an extended period, with life support maintained by intravenous isoprenaline infusion. On 10 May 1971, she underwent implantation of a self-designed inductive semi-implanted pacemaker via traditional thoracotomy. However, the device malfunctioned within hours due to a pulse sensor failure. Isoprenaline therapy was resumed while she awaited a second pacemaker. In June 1972, a novel pacemaker incorporating a thick-film circuit (Figure 1A, I) and a radiofrequency inductor coil (Figure 1A, II) was implanted. This device failed after 10 days due to lead fracture. Later in 1972, she received an implantable pacemaker from Siemens-Elema (Sweden), which functioned steadily for 2 years. From 1974 to 1982, she was implanted with domestic pacemakers, necessitating 10 replacements due to issues such as electrode corrosion, screw rusting, infections, and early battery depletion. Since 1982, pacemaker reliability has significantly improved, with device longevity extending to 5 years.1,2 The rapid advancement of pacemaker technology allowed her to gradually resume normal life and work. In December 2018 and 2023, she received her 22nd Medtronic pacemaker (Figure 1B, III) and her 23rd Micra leadless pacemaker (Figure 1C, IV, and D), respectively. Now, at 80 years old, she holds the record as the longest-surviving woman with pacemaker dependence, spanning 53 years.

(A) Thick-film circuit (I) and radiofrequency inductor coil (II). (B) Medtronic pacemaker (III). (C) Micra leadless pacemaker (IV). (D) Lateral view of (C).
Figure 1

(A) Thick-film circuit (I) and radiofrequency inductor coil (II). (B) Medtronic pacemaker (III). (C) Micra leadless pacemaker (IV). (D) Lateral view of (C).

Consent: The authors confirm that written consent for submission and publication of this case has been obtained from the patient in line with the Committee on Publication Ethics (COPE) guidelines.

Funding: This work was supported by the National Key Research and Development Program of China (number 2023YFB3208200), National Natural Science Function of China (82200488, 82370318, and 82070334), and Shanghai Pujiang Programme (23PJD081).

Data availability

The original data are available from the authors upon reasonable request.

References

1

Glikson
M
,
Nielsen
JC
,
Kronborg
MB
,
Michowitz
Y
,
Auricchio
A
,
Barbash
IM
, et al.
2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy
.
Eur Heart J
2021
;
42
:
3427
3520
.

2

Brunner
M
,
Olschewski
M
,
Geibel
A
,
Bode
C
,
Zehender
M
.
Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics
.
Eur Heart J
2004
;
25
:
88
95
.

Author notes

Conflict of interest: None declared.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Handling Editor: Fabian Barbieri
Fabian Barbieri
Handling Editor
Search for other works by this author on:

Editor: Ugur Canpolat,
Ugur Canpolat
Editor
Search for other works by this author on:
Armen Kocharian
Armen Kocharian
Editor
Search for other works by this author on:

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.